Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

Market Cap	1.07T
Revenue (ttm)	1.68T
Net Income (ttm)	189.04B
Shares Out	13.18M
EPS (ttm)	14,208.48
PE Ratio	5.74
Forward PE	n/a
Dividend	997.73 (1.22%)
Ex-Dividend Date	n/a

Volume	372
Average Volume	31,480
Open	80,800
Previous Close	80,800
Day's Range	80,500 - 81,000
52-Week Range	80,100 - 124,000
Beta	0.81
RSI	37.57
Earnings Date	Feb 3, 2025

About KRX:185750

Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. It provides prescription drugs for anticancer, anti-hypertension, anti-hyperlipidemia, anti-diabetic, and immunosuppressant products; over-the-counter drugs for therapeutic benefits, supplements, and other preventive products; health supplements with preventive benefits, including prebiotics and vitamins with Omega-3; and consumer health products, such as red-ginseng healthy drink, hand sanitizer, and hair colo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1941
• Employees: 2,276
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 185750

Financial Performance

In 2023, KRX:185750's revenue was 1.67 trillion, an increase of 12.17% compared to the previous year's 1.49 trillion. Earnings were 212.52 billion, an increase of 162.52%.